Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Scientists identify molecular pathway that plays a key role in stress-related DNA damage

Working closely with a team of researchers from Duke University, scientists from the Florida campus of The Scripps Research Institute have helped identify a molecular pathway that plays a key role in stress-related damage to the genome, the entirety of an organism's hereditary information.

23 Aug 2011

New report: Molecular imaging market to reach $6 billion by 2015

By 2015, it is anticipated that the molecular imaging (MI) market will achieve a value of over $6 billion, according to a new report on companiesandmarkets.com.

23 Aug 2011

Risk of Parkinson's disease increases with traumatic brain injury and exposure to pesticide paraquat

Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.

22 Aug 2011

Harnessing the brain’s capacity to adapt and regenerate

Understanding the brain’s capacity to adjust to physical and mental trauma and injury – and how to exploit this therapeutically to help patients – is the focus of a major international symposium at the University of New South Wales next month (8 Sept).

22 Aug 2011

Cellular pathology of Lou Gehrig’s disease discovered

Researchers claim to have found a common cause behind the mysterious and deadly affliction of amyotrophic lateral sclerosis, better known as Lou Gehrig’s disease. The discovery could pave the way to new treatments for the devastating disorder whose victims include top physicist Professor Stephen Hawking.

22 Aug 2011

Scientists identify common cause of all forms of amyotrophic lateral sclerosis

The underlying disease process of amyotrophic lateral sclerosis (ALS and Lou Gehrig's disease), a fatal neurodegenerative disease that paralyzes its victims, has long eluded scientists and prevented development of effective therapies. Scientists weren't even sure all its forms actually converged into a common disease process.

22 Aug 2011

Researchers to generate new knowledge about brain's complex communication system

Researchers at the Faculty of Pharmaceutical Sciences at the University of Copenhagen have collaborated with the company NeuroSearch to generate new knowledge about an important part of the brain's complex communication system.

20 Aug 2011

NIA awards UK Sanders-Brown Center on Aging ADC to continue Alzheimer's research

University of Kentucky officials announced this week that the UK Sanders-Brown Center on Aging (SBCoA) Alzheimer's Disease Center (ADC) is receiving more than $7 million from the National Institute on Aging (NIA), a division of the National Institutes of Health (NIH), to continue and further research and clinical initiatives geared toward treating Alzheimer's disease.

20 Aug 2011

NIH-supported project expands genetic research into clinical setting

Northwestern University Feinberg School of Medicine researchers have received a $762,000 grant from the National Institutes of Health (NIH) to tailor drug treatments to patients' genomic information.

20 Aug 2011

New Therapy Grants Program supports innovative approach to treat epilepsy

The Epilepsy Therapy Project (ETP) and the Epilepsy Foundation (EF) announced today a New Therapy Grant to potentially help those with treatment resistant epilepsy.

19 Aug 2011

Virginia Tech to create portable fall prediction monitoring system for the elderly

According to the U.S. Center for Disease Control and Prevention, falls among Americans over age 65 are the leading cause of injury-related death. Falls also are the most common cause of nonfatal injuries and hospital admissions for trauma. In 2007, more than 18,000 older adults died from unintentional fall injuries. In 2009, 2.2 million nonfatal fall injuries among elderly adults were treated in emergency rooms and more than 581,000 of these patients were hospitalized.

19 Aug 2011

Seven research teams across the U.S. to develop new drugs for nervous system disorders

The National Institutes of Health has made awards to investigators across the United States for an ambitious set of projects seeking to develop new drugs for disorders of the nervous system.

19 Aug 2011

Powerful X-rays help develop new drug treatment for malignant melanoma

Powerful X-ray technology developed at the U.S. Department of Energy's (DOE's) national laboratories is revealing new insights into diseases ranging from Alzheimer's to the swine flu, and, most recently, enabled the discovery of a groundbreaking new drug treatment for malignant melanoma, the deadliest form of skin cancer.

19 Aug 2011

DiaGenic reports operating revenue of NOK 1,151 thousand for second quarter 2011

DiaGenic: Important milestones achieved. DiaGenic's collaboration with Pfizer is the first collaboration between a diagnostics company and the market leader for Alzheimer's therapeutics that aims to identify blood based diagnostic tools that can detect early Alzheimer's disease, before the disease is clinically overt, or accessible to other either more invasive and costly or less precise diagnostic exploration.

19 Aug 2011

NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy

AMRI today announced it received a federal contract award from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) to provide chemistry and other drug discovery technologies in support of NINDS' Medicinal Chemistry for Neurotherapeutics Program (MCNP), part of the NIH Blueprint Neurotherapeutics Network.

19 Aug 2011

Medical research funding boost in UK

Health researchers in Cambridge have been awarded £114.5m to develop and translate new scientific discoveries into medicines and treatments. The funds come as a part of a five-year £800m investment by the National Institute for Health Research (NIHR).

18 Aug 2011

Cortex second quarter net loss decreases to $356,000

Cortex Pharmaceuticals, Inc. reported a net loss of approximately $356,000, or $0.00 per share, for the quarter ended June 30, 2011, compared with a net loss of approximately $2,454,000, or $0.04 per share, for the corresponding prior year period, with the difference reflecting revenues in the current year period from the Company's option agreement with Servier, France's largest privately held pharmaceutical company.

18 Aug 2011

Vitamin C shows promise against Alzheimer's disease

Researchers at Lund University have discovered a new function for vitamin C. Treatment with vitamin C can dissolve the toxic protein aggregates that build up in the brain in Alzheimer's disease.

18 Aug 2011

Researchers to unravel how brain makes everyday prognostications

Every day we make thousands of tiny predictions - when the bus will arrive, who is knocking on the door, whether the dropped glass will break. Now, in one of the first studies of its kind, researchers at Washington University in St. Louis are beginning to unravel the process by which the brain makes these everyday prognostications.

18 Aug 2011

Medicare Advantage plans may be counter-productive for the elderly

In health care, more choice may not always lead to better choices, particularly for the elderly. In a new study, researchers from Harvard Medical School's Department of Health Care Policy found that the large variety of managed care plans offered by the Medicare Advantage program may be counter-productive.

18 Aug 2011